Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric.

Published byLilli Becker Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric."— Presentation transcript:

1 Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and proportions of 396 individual caregivers or parents of children aged <5 years residing in the study area (x-axis) selecting the various healthcare services (y-axis) as first, second or third choices (see key for shading) for watery and mucoid diarrhoea. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 3. Medications sold by pharmacies in the study area for paediatric diarrhoea. (a) Rotated histogram showing the ... Figure 3. Medications sold by pharmacies in the study area for paediatric diarrhoea. (a) Rotated histogram showing the number and proportion (x-axis) of the 37 pharmacies visited during the ‘mystery shopper’ simulated client method selling between 1 and 5 medications (y-axis) for watery and mucoid diarrhoea, respectively. (b) Rotated histogram showing the number and proportion (x-axis) of the 37 pharmacies visited during the ‘mystery shopper’ simulated client method selling different mediations (y-axis) for watery and mucoid diarrhoea, respectively. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Figure 2. The geographical distribution of pharmacies in the Ho Chi Minh City study area. Maps of district 8 in Ho Chi ... Figure 2. The geographical distribution of pharmacies in the Ho Chi Minh City study area. Maps of district 8 in Ho Chi Minh City. (a) The point locations of pharmacies and the kernel distribution of pharmacy shop density. Green points identify the pharmacy shops and pharmacy density is determined by colour intensity (see key). (b) The distribution of pharmacy shops density per 10 000 inhabitants. The greater the intensity of red the higher the number of pharmacy shops per 10 000 people (see key, areas in grey are those with no data owing to missing data in the population raster). (c) The geographical areas in District 8 that are within 250 m of a pharmacy. Red shaded areas are locations in which residents live with 250 m of a location selling antimicrobials. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 1. Estimating antimicrobial usage for diarrhoea in children aged 1–5 years in pharmacies and hospital. Diagram ... Figure 1. Estimating antimicrobial usage for diarrhoea in children aged 1–5 years in pharmacies and hospital. Diagram outlining the sources of data, parameters, and calculations used to quantify antimicrobial usage for diarrhoea in children aged 1–5 years in this population. Note each of the parameters have been given an initial (A–F), which informs the calculations in Table 3. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric."

Similar presentations

J Exp Bot. 2017;68(17): doi: /jxb/erx352

J Exp Bot. 2017;68(17): doi: /jxb/erx352
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
Figure 1 The study area within Vienna Zoo is outlined in red

Figure 1 The study area within Vienna Zoo is outlined in red
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Top: Annual modal paternity distance (PDc) estimated for each of 23 cohorts by MasterBayes ... Figure 1 Top: Annual modal paternity distance (PDc)

Figure 1 Top: Annual modal paternity distance (PDc) estimated for each of 23 cohorts by MasterBayes ... Figure 1 Top: Annual modal paternity distance (PDc)
Figure 1 Study area in Northern Wisconsin, USA, where we simulated the dispersal of 15 translocated American martens ... Figure 1 Study area in Northern.

Figure 1 Study area in Northern Wisconsin, USA, where we simulated the dispersal of 15 translocated American martens ... Figure 1 Study area in Northern.
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.

Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.

Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.
Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA2020 ... Figure 1. Comparison of weighted.

Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.
Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
RCTs: randomized controlled ...

RCTs: randomized controlled ...

Similar presentations

Ads by Google